Citation

Jane Hitti, Janet Andersen, Grace McComsey, Tun Liu, Ann J. Melvin, Laura M. Smith, Alice M. Stek, Judith A. Aberg, Andrew D. Hull, Beverly L. Alston-Smith, Heather D. Watts, Elizabeth Livingston. Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS clinical trials group 5084. American Journal of Obstetrics and Gynecology. 2007. 196: 331.e1-7.

Citation

Sharon A. Riddler, Hongyu Jiang, Allan R. Tenorio, Hairong Huang, Daniel R. Kuritzkes, Edward P. Acosta, Alan Landay, Barbara Bastow, David W. Haas, Karen T. Tashima, Mamta Khandelwal Jain, Steven G. Deeks, John Alexander Bartlett. A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS clinical trials group study A5115. Antiviral Therapy. 2007. 12: 531-41.

Citation

Joseph J. Eron, Ronald J. Bosch, Daniel Bettendorf, Michael P. Bates, Leslie A. Petch, Susan A. Fiscus, Ian Frank. The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine. Journal of Acquired Immune Deficiency Syndromes. 2007. 45: 249-51.

Citation

David M. Margolis, Lisa Mukherjee, Courtney V. Fletcher, Evelyn Hogg, Debra M. Ogata-Arakaki, Tianna Petersen, Dave H. Rusin, Ana I. Martinez, John W. Mellors. The use of [beta]-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection. AIDS. 2007. 21: 2025-32.

Citation

Judith Silverstein Currier, Michelle A. Kendall, W. Keith Henry, Beverly L. Alston-Smith, Francesca J. Torriani, Pablo Tebas, Yanjie Li, Howard N. Hodis. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS. 2007. 21: 1137-45.

Citation

Roy (Trip) Gulick, Christina M. Lalama, Heather Ribaudo, Cecilia M. Shikuma, Bruce R. Schackman, Jeffrey T. Schouten, Kathleen E. Squires, Susan L. Koletar, Christopher D. Pilcher, Richard C. Reichman, Karin L. Klingman, Daniel R. Kuritzkes. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. AIDS. 2007. 21: 813-23.

Citation

Scott Evans, Carl J. Fichtenbaum, Judith A. Aberg. Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087. HIV Clinical Trials. 2007. 8: 45-52.

Citation

Edward P. Acosta, Michelle A. Kendall, John G. Gerber, Beverly L. Alston-Smith, Susan L. Koletar, Andrew R. Zolopa, Sangeeta Agarwala, Michael J. Child, Richard J. Bertz, Lara A. Hosey, David W. Haas. Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily. Antimicrobial Agents and Chemotherapy. 2007. 51: 3104-10.

Citation

Scott Evans, Tzu-min Yeh, Ned Sacktor, David B. Clifford, David M. Simpson, Eric N. Miller, Ronald J. Ellis, Victor G. Valcour, Christina M. Marra, Linda L. Millar, Giovanni Schifitto. Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clinical Trials. 2007. 8: 437-46.

Citation

Kim Keil, Jill S. Hochreiter, Robin DiFrancesco, Barry Zingman, Richard C. Reichman, Margaret A. Fischl, Barbara Gripshover, Gene D. Morse. Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application. Therapeutic Drug Monitoring. 2007. 29: 103-9.